“Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis.” Bridget F. Collins and Ganesh Raghu. Eur Respir Rev 2019; 28: 190022. Source: Eur Respir Rev, 28 (154) 195022; 10.1183/16000617.5022-2019 Year: 2019
“Do bacteria have a role in asthma development?” J. Armann and E. von Mutius. Eur Respir J 2010; 36: 469–471. Source: Eur Respir J, 54 (1) 1050414; 10.1183/13993003.50414-2010 Year: 2019
“A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice.” Akihiro Takemasa, Yoshiki Ishii and Takeshi Fukuda. Eur Respir J 2012; 40: 1475–1482. Source: Eur Respir J 2014; 44: 1101 Year: 2014
“Triple therapy in idiopathic pulmonary fibrosis: an alarming press release.” A.U. Wells, J. Behr, U. Costabel, V. Cottin and V. Poletti. Eur Respir J 2012; 39: 805–806. Source: Eur Respir J 2012; 39: 1552 Year: 2012
“Lung function race, ethnicity: a conundrum.” Philip H. Quanjer. Eur Respir J 2013; 41: 1249–1251. Source: Eur Respir J 2013; 42: 1162 Year: 2013
“Intersections of lung progenitor cells, lung disease and lung cancer.” Carla F. Kim. Eur Respir Rev 2017; 26: 170054. Source: Eur Respir Rev, 26 (146) 175054; 10.1183/16000617.5054-2017 Year: 2017
“Alveolar macrophages carbon load: a marker of exposure?” Chinedu Nwokoro, Rossa Brugha and Jonathan Grigg. Eur Respir J 2013; 41: 763. Source: Eur Respir J 2013; 42: 295 Year: 2013
COX-2 expression during early lung squamous cell carcinoma oncogenesis. C. Mascaux, B. Martin, J-M. Verdebout, V. Ninane and J-P. Sculier. Eur Respir J 2005; 26: 198-203. Source: Eur Respir J 2005; 26: 753 Year: 2005
“Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension.” Irene M. Lang and Sean P. Gaine. Eur Respir Rev 2015; 24: 630–641. Source: Eur Respir Rev 2015; 25: 99 Year: 2016
“Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice.” Stephen Y. Chan and Lewis J. Rubin. Eur Respir Rev 2017; 26: 170094. Source: Eur Respir Rev, 27 (147) 175094; 10.1183/16000617.5094-2017 Year: 2018
“RESPIRE: breathing new life into bronchiectasis.” Sanjay H. Chotirmall and James D. Chalmers. Eur Respir J 2018; 51: 1702444. Source: Eur Respir J, 51 (2) 1752444; 10.1183/13993003.52444-2017 Year: 2018
“The role of nebulised budesonide in the treatment of exacerbations of COPD.” H. Gunen, S.S. Hacievliyagil, O. Yetkin, G. Gulbas, L.C. Mutlu and E. In. Eur Respir J 2007; 29: 660–667. Source: Eur Respir J 2014; 44: 272 Year: 2014
“Mast cells promote lung vascular remodelling in pulmonary hypertension.” J. Hoffmann, J. Yin, M. Kukucka, N. Yin, I. Saarikko, A. Sterner-Kock, H. Fujii, H. Leong-Poi, H. Kuppe, R.T. Schermuly and W.M. Kuebler. Eur Respir J 2011; 37: 1400–1410. Source: Eur Respir J 2012; 40: 515-517 Year: 2012
“Dead space: the physiology of wasted ventilation.” H. Thomas Robertson. Eur Respir J 2015; 45: 1704–1716. Source: Eur Respir J 2015; 46: 1226 Year: 2015
“Microalbuminuria as a potential novel cardiovascular biomarker in patients with COPD.” Ciro Casanova and Bartolome R. Celli. Eur Respir J 2014; 43: 951–953. Source: Eur Respir J 2014; 43: 1825 Year: 2014
“Pioglitazone attenuates endotoxin-induced acute lung injury by reducing neutrophil recruitment.” Jochen Grommes, Mathias Mörgelin and Oliver Soehnlein. Eur Respir J 2012; 40: 416–423 Source: Eur Respir J, 56 (4) 1150910; 10.1183/13993003.50910-2011 Year: 2020
“The therapy of idiopathic pulmonary fibrosis: what is next?” Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi, et al . Eur Respir Rev 2019; 28: 190021. Source: Eur Respir Rev, 28 (153) 195021; 10.1183/16000617.5021-2019 Year: 2019
“Exercise pulmonary haemodynamics: a test in search of purpose.” J. Gerry Coghlan and Harm Jan Bogaard. Eur Respir J 2016; 47: 1315–1317. Source: Eur Respir J 2016; 48: 285 Year: 2016
“Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes.” Sabina A. Guler, Joanne M. Kwan, Janice M. Leung, Nasreen Khalil, Pearce G. Wilcox and Christopher J. Ryerson. Eur Respir J 2020; 55: 1900647. Source: Eur Respir J, 55 (3) 1950647; 10.1183/13993003.50647-2019 Year: 2020
“Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis.” Yasuhiro Kondoh, Vincent Cottin and Kevin K. Brown. Eur Respir Rev 2017; 26: 170050. Source: Eur Respir Rev, 27 (148) 175050; 10.1183/16000617.5050-2017 Year: 2018